Correlation Between Vertex Pharmaceuticals and ALK Abell
Can any of the company-specific risk be diversified away by investing in both Vertex Pharmaceuticals and ALK Abell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vertex Pharmaceuticals and ALK Abell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vertex Pharmaceuticals and ALK Abell AS, you can compare the effects of market volatilities on Vertex Pharmaceuticals and ALK Abell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vertex Pharmaceuticals with a short position of ALK Abell. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vertex Pharmaceuticals and ALK Abell.
Diversification Opportunities for Vertex Pharmaceuticals and ALK Abell
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Vertex and ALK is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Vertex Pharmaceuticals and ALK Abell AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALK Abell AS and Vertex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vertex Pharmaceuticals are associated (or correlated) with ALK Abell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALK Abell AS has no effect on the direction of Vertex Pharmaceuticals i.e., Vertex Pharmaceuticals and ALK Abell go up and down completely randomly.
Pair Corralation between Vertex Pharmaceuticals and ALK Abell
Given the investment horizon of 90 days Vertex Pharmaceuticals is expected to under-perform the ALK Abell. In addition to that, Vertex Pharmaceuticals is 1.39 times more volatile than ALK Abell AS. It trades about -0.21 of its total potential returns per unit of risk. ALK Abell AS is currently generating about -0.19 per unit of volatility. If you would invest 2,205 in ALK Abell AS on October 16, 2024 and sell it today you would lose (175.00) from holding ALK Abell AS or give up 7.94% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vertex Pharmaceuticals vs. ALK Abell AS
Performance |
| Timeline |
| Vertex Pharmaceuticals |
| ALK Abell AS |
Vertex Pharmaceuticals and ALK Abell Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vertex Pharmaceuticals and ALK Abell
The main advantage of trading using opposite Vertex Pharmaceuticals and ALK Abell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vertex Pharmaceuticals position performs unexpectedly, ALK Abell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALK Abell will offset losses from the drop in ALK Abell's long position.| Vertex Pharmaceuticals vs. Biomarin Pharmaceutical | Vertex Pharmaceuticals vs. Sarepta Therapeutics | Vertex Pharmaceuticals vs. Alnylam Pharmaceuticals | Vertex Pharmaceuticals vs. Intellia Therapeutics |
| ALK Abell vs. Novo Nordisk AS | ALK Abell vs. Novo Nordisk AS | ALK Abell vs. Vertex Pharmaceuticals | ALK Abell vs. CSL |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |